Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The recent approval of the first oral fecal-derived microbiota therapy to prevent the recurrence of Clostridioides difficile (C. diff) infection in patients was welcome news for physicians who've ...

U.S. health officials on Wednesday approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants.

The Food and Drug Administration has approved a fecal microbiota pill to treat recurrent infections caused by Clostridium difficile (C. diff), an antibiotic-resistant bacterium deemed an urgent threat ...

Vowst (fecal microbiota spores, live-brpk) can cause side effects that range from mild to serious. More common side effects include tiredness and constipation. If side effects from Vowst become ...

Please provide your email address to receive an email when new articles are posted on . “The availability of a fecal microbiota product that can be taken orally is a significant step forward in ...

OMAHA, Neb.--(BUSINESS WIRE)--Amber Specialty Pharmacy, an innovator and leader in the specialty pharmacy industry, has been selected as one of only two pharmacies nationally selected by Aimmune ...

WASHINGTON — U.S. health officials have approved the first pill made from healthy bacteria found in human waste to fight dangerous gut infections — an easier way of performing so-called fecal ...

The supply chain for Seres Therapeutics Inc.’s oral microbiome therapeutic Vowst, formerly known as SER-109, to prevent recurrent Clostridium difficile infection (rCDI) is “well-established,” said ...

The Food and Drug Administration on Wednesday approved a new drug from Seres Therapeutics that uses bacteria to treat a bowel disorder, making it the second microbiome therapy to hit the market. The ...

Seres Therapeutics has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with ...